Alzamend Neuro ALZN
NASDAQ ALZN
$1.25 -0.05 (-3.85%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alzamend Neuro (ALZN) Common Stock Issued (2021 - 2026)

Updated

Analysis

Alzamend Neuro (ALZN) Common Stock Issued (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 359.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 9.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Alzamend Neuro 5.73 Mn -9.73 Mn - 669,272.00
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 669,272.00
Apr 30, 2025 841,728.00
Jan 31, 2025 688,700.00
Apr 30, 2024 269,888.00
Jan 31, 2024 964,450.00
Apr 30, 2022 4.00 Mn
Jan 31, 2022 400.00
Oct 31, 2021 700.00
Jul 31, 2021 14.91 Mn
API Access

Alzamend Neuro Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=ALZN&period=max&api_key=YOUR_API_KEY